- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Monday, 24 December 2001
-
Current Status:
Answered by Malcolm Chisholm on 21 January 2002
To ask the Scottish Executive, further to the publication of the Scottish Health Plan, Our National Health: A plan for action, a plan for change, what funding the Scottish Community Diet Project received, or will receive, in (a) 2000-01, (b) 2001-02 and (c) 2002-03.
Answer
The Scottish Community Diet Project received £197,843 and £294,615 in 2000-01 and 2001-02 respectively, and is due to receive £381,350 in 2002-03. As specified in the Our National Health commitment, the grant provided in 2000-01 included an increase to allow the project to support over 50% more projects than previously budgeted for.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Monday, 07 January 2002
-
Current Status:
Answered by Malcolm Chisholm on 21 January 2002
To ask the Scottish Executive, further to the publication of the Scottish Health Plan, Our National Health: A plan for action, a plan for change, when it plans to create (a) a central innovation fund and (b) a Centre for Change and Innovation for the NHS.
Answer
Significant levels of funding are already being invested in innovation and modernisation of the NHS. Proposals for the Centre for Change and Innovation and a central innovation fund are currently being finalised and details will be announced shortly.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Friday, 21 December 2001
-
Current Status:
Answered by Malcolm Chisholm on 18 January 2002
To ask the Scottish Executive whether it will designate hepatitis C as a notifiable illness.
Answer
The Public Health (Notification of Infectious Diseases) (Scotland) Regulations 1988 require medical practitioners to notify viral hepatitis as an infectious disease.In addition, the Scottish Centre for Infection and Environmental Health operates an enhanced hepatitis C infection database, developed in collaboration with the key hepatitis testing laboratories, which is believed to have an under-reporting rate of less than 1%.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Thursday, 20 December 2001
-
Current Status:
Answered by Malcolm Chisholm on 17 January 2002
To ask the Scottish Executive whether funding applications submitted to the Chief Scientist Office can only propose using researchers who are based in Scotland.
Answer
Funding applications submitted to the Chief Scientist Office (CSO) can propose using researchers based outside Scotland but the principal research grant holder must be a permanent salaried member of staff in a Scottish Institution and the administering body must be based in Scotland. Further information on CSO grant conditions is available on the CSO website at www.show.scot.nhs.uk/cso/.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Thursday, 20 December 2001
-
Current Status:
Answered by Hugh Henry on 17 January 2002
To ask the Scottish Executive when it intends to publish its consultation paper on mental health services for deaf and deafblind people.
Answer
There has been no public commitment made by the Scottish Executive to consult on mental health services for deaf and deafblind people.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Tuesday, 18 December 2001
-
Current Status:
Answered by Malcolm Chisholm on 15 January 2002
To ask the Scottish Executive what research projects on child and adolescent mental health are currently under way in the NHS in Scotland and how much funding it is providing to each project.
Answer
The Chief Scientist Office (CSO) within the Scottish Executive Health Department has responsibility for encouraging and supporting research into health services and patient care within the NHS in Scotland. CSO directly funds three projects on child and adolescent mental health research. Details are as follows:
Adolescents with psychosis in Scotland: prevalence, health service use and disabilities. Cost: £116,134. A pilot study using fMRI to image imitation in autistic spectrum disorders. Cost: £66,165. Prosodic skills in children with autism. Cost: £135,438. In addition, information provided to CSO by NHS Trusts suggests that the NHS R & D Support Fund indirectly supported 359 research projects into mental health, at a total cost of £2,729,260 in the last financial year. It is not known what proportion of these projects deal specifically with child and adolescent mental health. Details of all current and recently completed research projects can be found in the National Research Register, a copy of which is available in the Parliament's Reference Centre (Bib. number 17404).
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Thursday, 08 November 2001
-
Current Status:
Answered by Malcolm Chisholm on 8 January 2002
To ask the Scottish Executive what plans it has to ensure that prevention of, and rehabilitation from, major injury receives a high profile in the interests of public health.
Answer
Our National Health: A plan for action, a plan for change confirmed the Executive's commitment to working with others to move the focus of health policy and health services from treatment to prevention. While occupational health and safety is a reserved matter, it has a strong bearing on many devolved areas, such as health, local government, transport and the environment. The Executive has been tackling this broad agenda in partnership with the UK government, Scottish local authorities, NHSScotland, the CBI, the TUC, the Federation of Small Businesses, the British Chambers of Commerce, Scotland's Health at Work, the Royal Society for the Prevention of Accidents and others. This joint activity includes, for example, the Revitalising Health and Safety initiative; Securing Health Together - a long-term occupational strategy for Scotland, England and Wales; Towards a Safer, Healthier Workplace, the occupational health and safety strategy for NHSScotland, and Tomorrow's Roads - safer for everyone, a strategy to reduce the number of people killed or seriously injured in road accidents in Great Britain by 40% by 2010. The Health and Safety Executive is also contributing to the Job Retention and Rehabilitation Pilot, led by the Department of Work and Pensions.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Tuesday, 11 December 2001
-
Current Status:
Answered by Malcolm Chisholm on 25 December 2001
To ask the Scottish Executive what representations it has made to Her Majesty's Government about improving the warning of side effects on the label carried by the acne drug Isotretinoin for the benefit of GPs and patients and, if it has not, whether it will make such representations
Answer
The Executive has not made any such representations and has no plans to do so.The Medicines Control Agency continuously monitors the safety of all medicines. If new side effects are detected, the product information is updated to ensure it contains all of the available information to aid the safe use of the medicine. The adverse reactions known to be associated with Roaccutane treatment are fully described in the product information, which consists of a Summary of Product Characteristic for healthcare professionals and a Patient Information Leaflet for patients.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Wednesday, 05 December 2001
-
Current Status:
Answered by Malcolm Chisholm on 19 December 2001
To ask the Scottish Executive what percentage of patients who have been prescribed Isotretinoin since 1999 suffer from mild or moderate acne.
Answer
The information requested is not available.
- Asked by: Nicola Sturgeon, MSP for Glasgow, Scottish National Party
-
Date lodged: Wednesday, 05 December 2001
-
Current Status:
Answered by Malcolm Chisholm on 19 December 2001
To ask the Scottish Executive whether it has any plans to recommend that independent research be carried out to establish how Isotretinoin functions in the human body and to determine what chemically-induced changes in the brain and in other parts of the body arise from ingesting the drug.
Answer
The Chief Scientist Office (CSO) within the Scottish Executive Health Department has responsibility for encouraging and supporting research into health services and patient care within the NHS in Scotland. The CSO has no plans for research into Isotretinoin but would be pleased to consider research proposals, which would be subject to the usual peer and committee review.
